ReMedium Advance S
Soft cross-linked hyaluronic-acid body filler (20 mg/ml, 10 ml) for breast fullness and figure balance.
Variants
| Volume |
|---|
| 10 ml |
Specifications
Brand
- Manufacturer
- Forever18 International Co., Ltd.
- Country Of Origin
- South Korea
Composition
- HA concentration
- 20 mg/ml
- Cross-linking technology
- Monophasic
- Contains lidocaine
- Not Contains
- Cross-linking agent
- DVS
Treatment
- Treatment areas
- Body contouring
- Longevity
- 12 months
Regulatory
- Country of origin
- South Korea
- Regulatory status
CE mark
Packaging
- Storage temperature
- Room temperature (up to 25 °C)
Overview
ReMedium Advance S is the soft formulation of the ReMedium Advance range, a cross-linked hyaluronic-acid (HA) body filler made of HA microbeads. It is positioned by the manufacturer for increasing breast fullness and projection, improving figure balance and body contouring.
Specifications
- Formulation: soft
- Material: cross-linked hyaluronic-acid microbeads
- HA concentration: 20 mg/ml
- Presentation: 10 ml
- Manufacturer: BioPlus Co., Ltd., South Korea
Technology
The ReMedium Advance range uses high-cross-linking HA microbeads and the manufacturer's patented multi-stage cross-linking technology, described as giving high viscosity, cohesiveness, moldability and shape retention.
Compared with Advance H
Advance S is the softer option, positioned mainly for breast and upper-body contouring. ReMedium Advance H is the harder option, positioned mainly for upper-buttock contouring. Both are 20 mg/ml, 10 ml cross-linked HA body fillers.
Safety and use
This is an injectable medical aesthetic product for use by licensed practitioners only. The manufacturer's materials list possible complications including pain, swelling, bruising, itching, infection, allergic reactions, palpable masses, asymmetry, ischemia and skin necrosis. Clinician assessment and post-treatment precautions are recommended. Specifications on this page do not replace the current instructions for use (IFU). Confirm certification, market authorization, composition and recommended needle or cannula with the manufacturer or an authorized distributor for your country before any clinical decision.